Published in Infect Immun on March 10, 2014
Human neutrophil peptides inhibit cleavage of von Willebrand factor by ADAMTS13: a potential link of inflammation to TTP. Blood (2016) 0.88
Delineation of interfaces on human alpha-defensins critical for human adenovirus and human papillomavirus inhibition. PLoS Pathog (2014) 0.86
Molecular basis for self-assembly of a human host-defense peptide that entraps bacterial pathogens. J Am Chem Soc (2014) 0.82
Thermodynamic instability of viral proteins is a pathogen-associated molecular pattern targeted by human defensins. Sci Rep (2016) 0.75
Targeting and inactivation of bacterial toxins by human defensins. Biol Chem (2017) 0.75
A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65
Antimicrobial peptides of multicellular organisms. Nature (2002) 23.50
ExPASy: The proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res (2003) 17.39
Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol (2003) 11.11
A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc Natl Acad Sci U S A (1989) 9.79
Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest (1985) 8.63
A Salmonella locus that controls resistance to microbicidal proteins from phagocytic cells. Science (1989) 7.58
Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol (2009) 6.10
Mammalian defensins in the antimicrobial immune response. Nat Immunol (2005) 4.84
Salmonella typhimurium phoP virulence gene is a transcriptional regulator. Proc Natl Acad Sci U S A (1989) 4.62
Primary structures of three human neutrophil defensins. J Clin Invest (1985) 3.70
Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils. J Biol Chem (1985) 3.58
Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II. Science (2010) 2.50
Human α-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets. Science (2012) 2.44
Interactions between human defensins and lipid bilayers: evidence for formation of multimeric pores. Protein Sci (1994) 2.43
Concurrent assessment of inner and outer membrane permeabilization and bacteriolysis in E. coli by multiple-wavelength spectrophotometry. J Immunol Methods (1988) 2.31
The role of cathelicidins in the innate host defenses of mammals. Curr Issues Mol Biol (2005) 1.94
Crystal structures of human alpha-defensins HNP4, HD5, and HD6. Protein Sci (2006) 1.68
Criterion for amino acid composition of defensins and antimicrobial peptides based on geometry of membrane destabilization. J Am Chem Soc (2011) 1.48
Functional analysis of the alpha-defensin disulfide array in mouse cryptdin-4. J Biol Chem (2004) 1.36
Defensins: antimicrobial peptides of vertebrates. C R Biol (2004) 1.29
Toward understanding the cationicity of defensins. Arg and Lys versus their noncoded analogs. J Biol Chem (2007) 1.28
Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid II. FEBS Lett (2010) 1.26
Reconstruction of the conserved beta-bulge in mammalian defensins using D-amino acids. J Biol Chem (2005) 1.25
Structural determinants of procryptdin recognition and cleavage by matrix metalloproteinase-7. J Biol Chem (2002) 1.20
Interactions of mouse Paneth cell alpha-defensins and alpha-defensin precursors with membranes. Prosegment inhibition of peptide association with biomimetic membranes. J Biol Chem (2003) 1.20
Structure-activity determinants in paneth cell alpha-defensins: loss-of-function in mouse cryptdin-4 by charge-reversal at arginine residue positions. J Biol Chem (2003) 1.19
Why is the Arg5-Glu13 salt bridge conserved in mammalian alpha-defensins? J Biol Chem (2005) 1.17
The conserved salt bridge in human alpha-defensin 5 is required for its precursor processing and proteolytic stability. J Biol Chem (2008) 1.16
Isolation, characterization, cDNA cloning, and antimicrobial properties of two distinct subfamilies of alpha-defensins from rhesus macaque leukocytes. Infect Immun (1999) 1.16
Neutrophil-derived defensins as modulators of innate immune function. Crit Rev Immunol (2008) 1.13
Trp-26 imparts functional versatility to human alpha-defensin HNP1. J Biol Chem (2010) 1.12
Solution structures of the rabbit neutrophil defensin NP-5. J Mol Biol (1988) 1.09
Structural and functional characterization of the conserved salt bridge in mammalian paneth cell alpha-defensins: solution structures of mouse CRYPTDIN-4 and (E15D)-CRYPTDIN-4. J Biol Chem (2006) 1.08
NMR studies of defensin antimicrobial peptides. 2. Three-dimensional structures of rabbit NP-2 and human HNP-1. Biochemistry (1992) 1.07
Electropositive charge in alpha-defensin bactericidal activity: functional effects of Lys-for-Arg substitutions vary with the peptide primary structure. Infect Immun (2009) 1.04
Quantitative interactions between cryptdin-4 amino terminal variants and membranes. Peptides (2003) 1.04
Mechanisms of alpha-defensin bactericidal action: comparative membrane disruption by Cryptdin-4 and its disulfide-null analogue. Biochemistry (2008) 1.04
Interactions of monomeric rabbit neutrophil defensins with bilayers: comparison with dimeric human defensin HNP-2. Biochemistry (1996) 1.03
Selective arginines are important for the antibacterial activity and host cell interaction of human alpha-defensin 5. FEBS Lett (2009) 1.03
In vitro activation of the rhesus macaque myeloid alpha-defensin precursor proRMAD-4 by neutrophil serine proteinases. J Biol Chem (2008) 0.95
Solution structure of cryptdin-4, a mouse paneth cell alpha-defensin. Biochemistry (2004) 0.93
Three-dimensional structure of RK-1: a novel alpha-defensin peptide. Biochemistry (2000) 0.90
The α-defensin salt-bridge induces backbone stability to facilitate folding and confer proteolytic resistance. Amino Acids (2012) 0.89
Expression and purification of recombinant alpha-defensins and alpha-defensin precursors in Escherichia coli. Methods Mol Biol (2010) 0.83
Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep (2013) 5.38
Antimicrobial peptides from human platelets. Infect Immun (2002) 2.32
Disruption of Paneth and goblet cell homeostasis and increased endoplasmic reticulum stress in Agr2-/- mice. Dev Biol (2009) 1.68
Criterion for amino acid composition of defensins and antimicrobial peptides based on geometry of membrane destabilization. J Am Chem Soc (2011) 1.48
Homodimeric theta-defensins from rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides. J Biol Chem (2001) 1.41
alpha-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors. AIDS (2003) 1.34
Alpha-defensins in enteric innate immunity: functional Paneth cell alpha-defensins in mouse colonic lumen. J Biol Chem (2009) 1.28
Bovine peptidoglycan recognition protein-S: antimicrobial activity, localization, secretion, and binding properties. J Immunol (2006) 1.24
Structure-activity determinants in paneth cell alpha-defensins: loss-of-function in mouse cryptdin-4 by charge-reversal at arginine residue positions. J Biol Chem (2003) 1.19
Isolation, characterization, and antimicrobial properties of bovine oligosaccharide-binding protein. A microbicidal granule protein of eosinophils and neutrophils. J Biol Chem (2002) 1.18
Microbicidal properties and cytocidal selectivity of rhesus macaque theta defensins. Antimicrob Agents Chemother (2007) 1.13
Strain-specific polymorphisms in Paneth cell α-defensins of C57BL/6 mice and evidence of vestigial myeloid α-defensin pseudogenes. Infect Immun (2010) 1.06
θ-Defensins: cyclic peptides with endless potential. J Biol Chem (2012) 1.05
Electropositive charge in alpha-defensin bactericidal activity: functional effects of Lys-for-Arg substitutions vary with the peptide primary structure. Infect Immun (2009) 1.04
Quantitative interactions between cryptdin-4 amino terminal variants and membranes. Peptides (2003) 1.04
Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes. Infect Immun (2008) 1.03
Cyclic and acyclic defensins inhibit human immunodeficiency virus type-1 replication by different mechanisms. PLoS One (2010) 1.03
CXCL17 is a mucosal chemokine elevated in idiopathic pulmonary fibrosis that exhibits broad antimicrobial activity. J Immunol (2012) 1.00
Paneth cell alpha-defensins from rhesus macaque small intestine. Infect Immun (2004) 0.98
Rhesus theta-defensin prevents death in a mouse model of severe acute respiratory syndrome coronavirus pulmonary disease. J Virol (2009) 0.96
Anionic amino acids near the pro-alpha-defensin N terminus mediate inhibition of bactericidal activity in mouse pro-cryptdin-4. J Biol Chem (2008) 0.95
In vitro activation of the rhesus macaque myeloid alpha-defensin precursor proRMAD-4 by neutrophil serine proteinases. J Biol Chem (2008) 0.95
Rhesus macaque θ-defensin isoforms: expression, antimicrobial activities, and demonstration of a prominent role in neutrophil granule microbicidal activities. J Leukoc Biol (2010) 0.94
Rhesus macaque theta defensins suppress inflammatory cytokines and enhance survival in mouse models of bacteremic sepsis. PLoS One (2012) 0.89
The α-defensin salt-bridge induces backbone stability to facilitate folding and confer proteolytic resistance. Amino Acids (2012) 0.89
Arginine in α-defensins: differential effects on bactericidal activity correspond to geometry of membrane curvature generation and peptide-lipid phase behavior. J Biol Chem (2012) 0.89
Paneth cell-mediated multiorgan dysfunction after acute kidney injury. J Immunol (2012) 0.87
The cell-penetrating peptide, Pep-1, has activity against intracellular chlamydial growth but not extracellular forms of Chlamydia trachomatis. J Antimicrob Chemother (2008) 0.86
Cycloquest: identification of cyclopeptides via database search of their mass spectra against genome databases. J Proteome Res (2011) 0.85
Elevated expression of Paneth cell CRS4C in ileitis-prone SAMP1/YitFc mice: regional distribution, subcellular localization, and mechanism of action. J Biol Chem (2010) 0.85
Persistence of gut mucosal innate immune defenses by enteric α-defensin expression in the simian immunodeficiency virus model of AIDS. J Immunol (2010) 0.84
Antimicrobial properties of the Escherichia coli R1 plasmid host killing peptide. J Biotechnol (2003) 0.84
High fidelity processing and activation of the human α-defensin HNP1 precursor by neutrophil elastase and proteinase 3. PLoS One (2012) 0.83
Expression and purification of recombinant alpha-defensins and alpha-defensin precursors in Escherichia coli. Methods Mol Biol (2010) 0.83
Alternative luminal activation mechanisms for paneth cell α-defensins. J Biol Chem (2012) 0.82
Cryptdin 3 forms anion selective channels in cytoplasmic membranes of human embryonic kidney cells. Am J Physiol Gastrointest Liver Physiol (2002) 0.79
Synthesis, structure, and activities of an oral mucosal alpha-defensin from rhesus macaque. J Biol Chem (2008) 0.78
SDF2L1, a component of the endoplasmic reticulum chaperone complex, differentially interacts with {alpha}-, {beta}-, and {theta}-defensin propeptides. J Biol Chem (2008) 0.76
RTD-1mimic containing γPNA scaffold exhibits broad-spectrum antibacterial activities. J Am Chem Soc (2012) 0.76
Alpha-defensin expression during myelopoiesis: identification of cis and trans elements that regulate expression of NP-3 in rat promyelocytes. J Leukoc Biol (2003) 0.76
Inhibition of bactericidal activity is maintained in a mouse alpha-defensin precursor with proregion truncations. Peptides (2009) 0.76
Immunology. HD6 defensin nanonets. Science (2012) 0.75
Small-angle X-ray scattering studies of peptide-lipid interactions using the mouse paneth cell α-defensin cryptdin-4. Methods Enzymol (2011) 0.75